+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3D Printed Drugs Market by 3D Printing Technology (Fused Deposition Modeling, Inkjet Printing, Selective Laser Sintering), Dosage Form (Capsules, Nanoparticles, Tablets), Drug Release, Therapeutic Area, End User - Global Forecast 2025-2030- Product Image
3D Printed Drugs Market by 3D Printing Technology (Fused Deposition Modeling, Inkjet Printing, Selective Laser Sintering), Dosage Form (Capsules, Nanoparticles, Tablets), Drug Release, Therapeutic Area, End User - Global Forecast 2025-2030- Product Image
Sale

3D Printed Drugs Market by 3D Printing Technology (Fused Deposition Modeling, Inkjet Printing, Selective Laser Sintering), Dosage Form (Capsules, Nanoparticles, Tablets), Drug Release, Therapeutic Area, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4857884
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The 3D Printed Drugs Market is gaining strategic importance in the pharmaceutical landscape, as advanced additive manufacturing technologies unlock new models for precision medicine and agile supply chains. Senior leaders are closely monitoring this sector to assess emerging opportunities for therapeutic innovation, regulatory adaptation, and business transformation.

Market Snapshot: Growth Outlook for the 3D Printed Drugs Market

The 3D Printed Drugs Market grew from USD 178.43 million in 2024 to USD 202.89 million in 2025 and is forecast to reach USD 400.97 million by 2030, advancing at a CAGR of 14.44%. This expansion reflects accelerating adoption of three-dimensional printing capabilities for pharmaceutical manufacturing, propelled by demand for personalized dosing, supply chain optimization, and novel drug delivery formats. Market momentum is strongest across established healthcare hubs with supportive regulatory and funding environments, while emerging regions are leveraging decentralized manufacturing to expand access and drive local innovation.

Scope & Segmentation

  • 3D Printing Technologies: Fused deposition modeling, inkjet printing, selective laser sintering, and stereolithography. Includes nozzle-based and pellet-based variants.
  • Dosage Forms: Capsules, nanoparticles, tablets.
  • Drug Release Profiles: Controlled release, delayed release, immediate release.
  • Therapeutic Areas: Cardiovascular, dental, neurology, oncology.
  • End Users: Contract research organizations, hospitals and clinics, pharmaceutical companies, research institutes.
  • Regional Coverage: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: 3D Systems, Inc.; Aprecia Pharmaceuticals, LLC; Anatomics Pty Ltd.; Curify Ltd; 3D Bioprinting Solutions Ltd; Cyfuse Biomedical K.K.; FabRx Ltd.; GlaxoSmithKline Plc; Laxxon Medical Corp.; MB Therapeutics; Merck KGaA; Proto Labs Inc.; Renishaw PLC; Siemens AG; Triastek, Inc.; Yissum.

Key Takeaways & Strategic Insights

  • 3D printed drugs are enabling a shift from standardized dosage forms to highly customizable therapeutic regimens, increasing patient adherence and treatment precision.
  • Additive manufacturing platforms improve supply chain agility by enabling localized, on-demand production and reducing dependency on traditional inventory models.
  • Collaborative partnerships are forming between hardware manufacturers, academic researchers, pharmaceutical formulators, and healthcare providers to accelerate end-to-end drug development workflows.
  • Regulatory bodies are evolving frameworks to address digital file governance, process validation, and quality control issues unique to three-dimensional printing, supporting smoother transitions from lab innovation to market deployment.
  • Pioneering companies are demonstrating the feasibility of layer-by-layer fabrication in challenging therapeutic areas, including orphan diseases and implantable devices, broadening the scope of future drug delivery possibilities.
  • Decentralized microfactories and hospital-based printing hubs are being explored to expand patient access and streamline clinical response in both developed and emerging healthcare markets.

Tariff Impact: Navigating U.S. Additive Manufacturing Supply Chain Challenges

Newly implemented United States tariffs on imported additive manufacturing components and raw materials, effective in 2025, have introduced cost pressures for domestic pharmaceutical producers. Procurement costs for key inputs such as polymer feedstocks, nozzles, and photopolymer resins may affect capital investment cycles or compress operating margins. Organizations are responding by diversifying sourcing arrangements, negotiating with domestic suppliers, and researching recyclable or bio-based alternatives to bolster supply chain resilience. These responses help safeguard production continuity amid ongoing trade and policy uncertainties.

Methodology & Data Sources

This report utilizes a hybrid research approach, drawing on primary interviews with industry executives and clinical practitioners combined with comprehensive secondary reviews of peer-reviewed journal articles, patent filings, and regulatory guidance. Data triangulation and expert peer review were applied to ensure objectivity and current market relevance.

Why This Report Matters for Decision-Makers

  • Delineates actionable growth opportunities and operational risks across key technologies, therapeutic segments, and regional markets.
  • Enables benchmarking of strategic initiatives in additive manufacturing adoption, regulatory compliance, and supply chain planning.
  • Supports senior leaders in evaluating investment strategies and partnership frameworks for the evolving 3D printed pharmaceuticals sector.

Conclusion

The 3D Printed Drugs Market is reshaping drug development pathways through advanced manufacturing and strategic collaboration. Decision-makers equipped with current, actionable insights will be best positioned to harness these evolving opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multi-drug compartment printing enabling targeted combination therapies in single pills
5.2. Adoption of bioprinting techniques for on-demand production of drug-loaded tissue scaffolds
5.3. Implementation of digital supply chain platforms ensuring traceability of 3D printed pharmaceutical products
5.4. Evolving regulatory frameworks addressing quality and safety standards for mass adoption of drug printing
5.5. Emergence of pediatric and geriatric tailored dosage printing to optimize pharmacokinetics in vulnerable populations
5.6. Application of smart sensor interfaces in 3D printed pills for real-time monitoring of patient adherence
5.7. Blockchain-enabled digital supply chain platforms for end-to-end traceability of 3D printed medications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. 3D Printed Drugs Market, by 3D Printing Technology
8.1. Introduction
8.2. Fused Deposition Modeling
8.2.1. Nozzle-Based
8.2.2. Pellet-Based
8.3. Inkjet Printing
8.4. Selective Laser Sintering
8.5. Stereolithography
9. 3D Printed Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsules
9.3. Nanoparticles
9.4. Tablets
10. 3D Printed Drugs Market, by Drug Release
10.1. Introduction
10.2. Controlled Release
10.3. Delayed Release
10.4. Immediate Release
11. 3D Printed Drugs Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.3. Dental
11.4. Neurology
11.5. Oncology
12. 3D Printed Drugs Market, by End User
12.1. Introduction
12.2. Contract Research Organizations
12.3. Hospitals & Clinics
12.4. Pharmaceutical Companies
12.5. Research Institutes
13. Americas 3D Printed Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa 3D Printed Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific 3D Printed Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. 3D Systems, Inc.
16.3.2. Aprecia Pharmaceuticals, LLC
16.3.3. Anatomics Pty Ltd.
16.3.4. Curify Ltd
16.3.5. Cyfuse Biomedical K.K.
16.3.6. FabRx Ltd.
16.3.7. GlaxoSmithKline Plc
16.3.8. Laxxon Medical Corp.
16.3.9. MB Therapeutics
16.3.10. Merck KGaA
16.3.11. Proto Labs Inc.
16.3.12. Renishaw PLC
16.3.13. Siemens AG
16.3.14. Triastek, Inc.
16.3.15. Yissum
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. 3D PRINTED DRUGS MARKET: RESEARCHAI
FIGURE 26. 3D PRINTED DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. 3D PRINTED DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. 3D PRINTED DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NOZZLE-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NOZZLE-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY PELLET-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY PELLET-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SELECTIVE LASER SINTERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DELAYED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DELAYED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. CANADA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. CANADA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 92. CANADA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 93. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 94. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 95. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 96. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 97. CANADA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 98. CANADA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 99. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 104. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 105. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 110. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 111. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 166. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 167. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 168. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 169. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 170. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 171. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 172. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 173. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 178. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 179. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 180. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 181. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 182. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 183. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 184. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 185. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ITALY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. ITALY 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. ITALY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 202. ITALY 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 203. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 204. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 205. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 206. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 207. ITALY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 208. ITALY 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 209. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 214. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 215. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 216. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 217. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 218. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 219. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 220. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 221. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 262. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 263. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 264. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 265. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 266. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 267. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 268. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 269. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. QATAR 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. QATAR 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. QATAR 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 286. QATAR 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 287. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 288. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 289. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 290. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 291. QATAR 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 292. QATAR 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 293. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 298. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 299. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 300. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 301. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 302. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 303. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 304. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 305. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 332. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY 3D PRINTING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 333. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2018-2024 (USD MILLION)
TABLE 334. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELING, 2025-2030 (USD MILLION)
TABLE 335. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 336. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 337. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2018-2024 (USD MILLION)
TABLE 338. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DRUG RELEASE, 2025-2030 (USD MILLION)
TABLE 339. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 340. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 341. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

  • 3D Systems, Inc.
  • Aprecia Pharmaceuticals, LLC
  • Anatomics Pty Ltd.
  • Curify Ltd
  • 3D Bioprinting Solutions Ltd
  • Cyfuse Biomedical K.K.
  • FabRx Ltd.
  • GlaxoSmithKline Plc
  • Laxxon Medical Corp.
  • MB Therapeutics
  • Merck KGaA
  • Proto Labs Inc.
  • Renishaw PLC
  • Siemens AG
  • Triastek, Inc.
  • Yissum

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 202.89 Million
Forecasted Market Value ( USD ) by 2030 $ 400.97 Million
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

3D Printed Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

3D Printed Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 81 Pages
  • Global
From
3D Printed Brain Model Market by Material (Acrylonitrile Butadiene Styrene, Metal Powders, Photopolymer Resin), Technology (Binder Jetting, Digital Light Processing, Fused Deposition Modeling), Application, End User - Global Forecast 2025-2030 - Product Image

3D Printed Brain Model Market by Material (Acrylonitrile Butadiene Styrene, Metal Powders, Photopolymer Resin), Technology (Binder Jetting, Digital Light Processing, Fused Deposition Modeling), Application, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
3D Printing in Healthcare. Novel Applications. Edition No. 1 - Product Image

3D Printing in Healthcare. Novel Applications. Edition No. 1

  • Book
  • 320 Pages
3D Printed Nanocellulose Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

3D Printed Nanocellulose Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 260 Pages
  • Global
From
3D Printed Nasal Swabs Market by End User (Ambulatory Care Centers, Diagnostic Laboratories, Home Care), Distribution Channel (Direct Tender, Distributor, Online Sales), Material, Technology, Application - Global Forecast 2025-2030 - Product Image

3D Printed Nasal Swabs Market by End User (Ambulatory Care Centers, Diagnostic Laboratories, Home Care), Distribution Channel (Direct Tender, Distributor, Online Sales), Material, Technology, Application - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From

About the 3D Printed Drug Market

The 3D Printed Drug market is a subset of the Pharmaceutical industry that focuses on the production of drugs using 3D printing technology. This technology allows for the production of drugs with complex geometries and shapes, as well as the ability to customize drugs for individual patients. 3D Printed Drugs are typically produced using a powder-based process, where a powder is spread over a build platform and then fused together using a laser. This process allows for the production of drugs with a high degree of accuracy and precision. The 3D Printed Drug market is expected to grow in the coming years, as the technology becomes more widely adopted. This growth is driven by the potential for improved drug efficacy, as well as the ability to customize drugs for individual patients. Some companies in the 3D Printed Drug market include Aprecia Pharmaceuticals, 3DPharma, and 3D4MD. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.